Normal view MARC view ISBD view

[Complications of cholelithiasis: a case report]. [electronic resource]

By:

Penkov, N

Contributor(s):

Producer: 19951220Description: 54-5 p. digitalISSN:

0450-2167

Subject(s):

In: Khirurgiia vol. 47

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Case Reports; Journal Article

There are no comments on this title.

to post a comment.

Back to results

6021 CHOP and rituximab in elderly patients.
by Portlock, Carol S
6022 [New options in treatment of therapy refractory vasculitis].
by Lamprecht, P
6023 186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma.
by Knop, Stefan
6024 Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?
by Willis, Monte S
6025 Posttransplant lymphoproliferative disease.
by Soltys, Kyle
6026 Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
by Kosugi, Satoru
6027 Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
by Omdal, R
6028 Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.
by Narimatsu, H
6029 Current approaches to treatment of antibody-mediated rejection.
by Jordan, Stanley C
6030 Rituximab in the treatment of acquired factor VIII inhibitors.
by Onitilo, Adedayo A
6031 Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
by Herbei, Lavinia
6032 Clinical and immunological worsening in a patient affected with Waldenstrom macroglobulinemia and anti-mag neuropathy after treatment with rituximab.
by Gironi, Maira
6033 [Rituximab: mechanism of action and resistance].
by Dalle, Stéphane
6034 Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
by Sacchi, Stefano
6035 New advances in antirejection therapy.
by Chan, Michael
6036 [Milestone in healing fatal indolent lymphoma].
6037 Primary follicular lymphoma of the small intestine.
by Chim, C S
6038 Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
by Lacouture, M E
6039 [Biological treatment of multiple sclerosis].
by Sørensen, Per Soelberg
6040 Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis.
by Silverman, Gregg J